126 related articles for article (PubMed ID: 27732894)
1. Development of aqueous dispersions of Coenzyme Q
Carvalho TC; McCook JP; Narain NR; McConville JT
Int J Pharm; 2016 Dec; 514(2):407-419. PubMed ID: 27732894
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of phospholipid-stabilized submicron aqueous dispersions of coenzyme Q₁₀ presenting continuous vibrating-mesh nebulization performance.
Carvalho TC; McCook JP; Narain NR; McConville JT
J Liposome Res; 2013 Dec; 23(4):276-90. PubMed ID: 23772691
[TBL] [Abstract][Full Text] [Related]
3. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
[TBL] [Abstract][Full Text] [Related]
4. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Ribavirin Aerosol With Small Particle Aerosol Generator and Vibrating Mesh Micropump Aerosol Technologies.
Walsh BK; Betit P; Fink JB; Pereira LM; Arnold J
Respir Care; 2016 May; 61(5):577-85. PubMed ID: 26932383
[TBL] [Abstract][Full Text] [Related]
6. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
7. Nebulized coenzyme Q
Rossi I; Sonvico F; McConville JT; Rossi F; Fröhlich E; Zellnitz S; Rossi A; Del Favero E; Bettini R; Buttini F
Eur J Pharm Sci; 2018 Feb; 113():159-170. PubMed ID: 29066385
[TBL] [Abstract][Full Text] [Related]
8. Surfactant and perfluorocarbon aerosolization by means of inhalation catheters for the treatment of respiratory distress syndrome: an in vitro study.
Murgia X; Gastiasoro E; Mielgo V; Alvarez-Diaz F; Lafuente H; Valls-i-Soler A; Gomez-Solaetxe MA; Larrabe JL; Rey-Santano C
J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):81-7. PubMed ID: 21410324
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
[TBL] [Abstract][Full Text] [Related]
10. Nebulization of active pharmaceutical ingredients with the eFlow(®) rapid: impact of formulation variables on aerodynamic characteristics.
Beck-Broichsitter M; Prüfer N; Oesterheld N; Seeger W; Schmehl T
J Pharm Sci; 2014 Aug; 103(8):2585-9. PubMed ID: 24986144
[TBL] [Abstract][Full Text] [Related]
11. The influence of fluid physicochemical properties on vibrating-mesh nebulization.
Ghazanfari T; Elhissi AM; Ding Z; Taylor KM
Int J Pharm; 2007 Jul; 339(1-2):103-11. PubMed ID: 17451896
[TBL] [Abstract][Full Text] [Related]
12. On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery.
Beck-Broichsitter M; Oesterheld N; Knuedeler MC; Seeger W; Schmehl T
Int J Pharm; 2014 Jan; 461(1-2):34-7. PubMed ID: 24291081
[TBL] [Abstract][Full Text] [Related]
13. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
14. The function and performance of aqueous aerosol devices for inhalation therapy.
Carvalho TC; McConville JT
J Pharm Pharmacol; 2016 May; 68(5):556-78. PubMed ID: 27061412
[TBL] [Abstract][Full Text] [Related]
15. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
[TBL] [Abstract][Full Text] [Related]
16. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
[TBL] [Abstract][Full Text] [Related]
17. Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.
Kleemann E; Schmehl T; Gessler T; Bakowsky U; Kissel T; Seeger W
Pharm Res; 2007 Feb; 24(2):277-87. PubMed ID: 17211729
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
[TBL] [Abstract][Full Text] [Related]
19. Polymer nanoparticle-based controlled pulmonary drug delivery.
Beck-Broichsitter M; Dalla-Bona AC; Kissel T; Seeger W; Schmehl T
Methods Mol Biol; 2014; 1141():133-45. PubMed ID: 24567136
[TBL] [Abstract][Full Text] [Related]
20. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child.
Lin HL; Wan GH; Chen YH; Fink JB; Liu WQ; Liu KY
Respir Care; 2012 Nov; 57(11):1894-900. PubMed ID: 22418694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
